SELUTION SLR™ wins historic US FDA nod for in‑stent restenosis The US Food and Drug Administration has approved the SELUTION SLR™ (Sustained Limus Release) Drug-Eluting Balloon for coronary in-stent restenosis (ISR), Cordis announced this month. This is the first and only sirolimus drug-eluting b